Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma

BACKGROUND: In the absence of clinical trials providing direct efficacy results, this study compares different methods of indirect treatment comparison (ITC), and their respective impacts on efficacy estimates for lenvatinib (LEN) plus everolimus (EVE) combination therapy compared to other second-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Tremblay, Gabriel, McElroy, Heather J., Westley, Tracy, Meier, Genevieve, Misurski, Derek, Guo, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400440/
https://www.ncbi.nlm.nih.gov/pubmed/30835737
http://dx.doi.org/10.1371/journal.pone.0212899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400440/
https://www.ncbi.nlm.nih.gov/pubmed/30835737
http://dx.doi.org/10.1371/journal.pone.0212899

Ejemplares similares